Pliant Therapeutics (PLRX) Preferred Dividend Payments (2019 - 2020)
Pliant Therapeutics' (PLRX) quarterly Preferred Dividend Payments came in at $11.0 million in Q1 2020, up 207.05% quarter-over-quarter from -$10.3 million in Q4 2019.
Powered by 
Analysis
Pliant Therapeutics (PLRX) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Preferred Dividend Payments for 2 consecutive years, with $11.0 million the latest figure, recorded in Q1 2020.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $11.0 million in Q1 2020; TTM through Mar 2021 was $2.1 million, a 39.28% decrease from a year earlier, with the FY2019 full-year figure at -$6.2 million, changed N/A from the prior year.
- Preferred Dividend Payments was $11.0 million for Q1 2020 at Pliant Therapeutics, up from -$10.3 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $11.0 million in Q1 2020 and troughed at -$10.3 million in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Pliant Therapeutics | 71.21 Mn | 71.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 11.03 Mn |
| Dec 31, 2019 | -10.30 Mn |
| Sep 30, 2019 | 1.38 Mn |
| Jun 30, 2019 | 1.36 Mn |